The main patent on Advair (fluticasone+salmeterol) expired as long ago as ... Novartis’ Sandoz generics arm, and Hikma have tried unsuccessfully to get copies approved, and the regulator had ...

a generic version of GlaxoSmithKline's Advair (fluticasone propionate/salmeterol) partnered with Hikma, and other inhaled and non-inhaled products that generate royalty streams. It also gets ...

Introduction: The incidence of asthma exacerbations in patients receiving salmeterol/fluticasone propionate (Seretide™ or Advair ®) is low. However, when asthma control deteriorates ...

Objective: To test the hypothesis that once-daily treatment with fluticasone propionate is as effective as twice-daily treatment in children with well controlled asthma. Design: Multicentre ...

London, United Kingdom – Hikma Pharmaceuticals PLC (Hikma, Group), the multinational pharmaceutical group, today provides an update on current trading. Riad Mishlawi, Hikma’s CEO, said: “I am pleased ...

Hikma started CohenCare in 2020 with 3 partners after recognizing a significant gap in compassionate home care options in her community. Her desire to create a nurturing environment for those in ...

Hikma Pharmaceuticals Usa Inc was founded in 2011 and operates in Eatontown, United States. The company engages in the sector 'Pharmaceuticals, Medicinal Chemical & Botanical Products' (ISIC: 2100 ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Fluticasone (brand name Flovent) is a prescription corticosteroid used to prevent breathing difficulties, chest tightness, wheezing and coughing caused by respiratory disorders such as COPD. It works ...

It seems that only certain subgroups of patients with COPD benefit from steroid treatment. A study was undertaken to examine whether inhaled fluticasone propionate (FP) had an effect on lung function ...